Top 10: Pharmaceutical Companies in Bulgaria
At a time of profound structural changes for the Bulgarian economy and the healthcare system, the pharmaceutical sector is establishing itself as one of the industries with the strongest and most multifaceted impact. In this context, Healthcare Magazine presents the Top 10: Pharmaceutical Companies in Bulgaria ranking—a look at the leading market players shaping not only the economic dynamics of the sector but also patients’ actual access to modern therapies.
The pharmaceutical companies included in this ranking collectively account for approximately half of the Rx market in our country. At the same time, each of them holds a market share of less than 10%—a testament to the absence of a dominant player and a relatively fragmented market.
The ranking illustrates the market positions by revenue of pharmaceutical companies in Bulgaria and their ability to successfully adapt to an environment of high regulation, accelerated scientific evolution, and growing public expectations. This is precisely where the three main themes of this issue intersect: science as the driver of innovation and new therapies; ethics related to accessibility, transparency, and responsibility toward patients; and economics, which, on the eve of the euro adoption, sets new requirements for efficiency, price sustainability, and long-term planning.
Top 10: Pharmaceutical Companies in Bulgaria 2024–2025
- Merck Sharp & Dohme (MSD)
- AstraZeneca
- Roche
- Swixx Biopharma
- Novartis
- AbbVie
- Pfizer
- Novo Nordisk
- Johnson & Johnson
- Astellas
*The ranking is provided by IQVIA and is prepared based on anonymized and aggregated annual market revenue data (rolling year average data: October 2024–September 2025).
READ
MORE
